De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course

被引：1

作者：

Ramachandran, Preethi ^{[1
]}

Sahni, Sonu ^{[1
]}

Wang, Jen C. ^{[1
]}

机构：

[1] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY 11212 USA

来源：

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS | 2019年 / 7卷

关键词：

DLBCL; gastrointestinal lymphoma; CD5+ lymphoma; B-cell lymphoma; small bowel lymphoma; CD5(+); EXPRESSION; TUMORS;

D O I：

10.1177/2324709619893546

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The gastrointestinal tract is a common extranodal site for lymphomas. However, primary gastrointestinal lymphomas are rare. Diffuse large B-cell lymphomas (DLBCL) are the most commonly encountered type in the gastrointestinal tract. Most of the DLBCL are CD5 negative. CD5+ DLBCL is very rare and a poor prognostic subtype of lymphoma. We report a rare case of primary small bowel CD5+ DLBCL that evolved from being a localized low International Prognostic Index-scored disease into an advanced and aggressive disease primarily dictated by the presence of CD5 antigen positivity.

引用

页数：5

共 50 条

[41] Secondary skin involvement by systemic de novo CD5-positive diffuse large B-cell lymphoma
Baba, Naoko
Fujii, Kazuyasu
Ibusuki, Atsuko
Higashi, Yuko
Kawai, Kazuhiro
Kanekura, Takuro
JOURNAL OF DERMATOLOGY, 2018, 45 (01): : E15 - E16
[42] PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF DE-NOVO CD5 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
MATOLCSY, A
CHADBURN, A
KNOWLES, DM
LABORATORY INVESTIGATION, 1995, 72 (01) : A116 - A116
[43] Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup:: Development of a CD5 signature
Suguro, Miyuki
Tagawa, Hiroyuki
Kagami, Yoshitoyo
Okamoto, Masataka
Ohshima, Koichi
Shiku, Hiroshi
Morishima, Yasuo
Nakamura, Shigeo
Seto, Masao
CANCER SCIENCE, 2006, 97 (09) : 868 - 874
[44] Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
Eugene Kim
Yanwen Jiang
Tao Xu
Alexandra Bazeos
Andrea Knapp
Christopher R. Bolen
Kathryn Humphrey
Tina G. Nielsen
Elicia Penuel
Joseph N. Paulson
BMC Cancer, 22
[45] Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
Kim, Eugene
Jiang, Yanwen
Xu, Tao
Bazeos, Alexandra
Knapp, Andrea
Bolen, Christopher R.
Humphrey, Kathryn
Nielsen, Tina G.
Penuel, Elicia
Paulson, Joseph N.
BMC CANCER, 2022, 22 (01)
[46] Flower-shaped lymphocytes in CD5+ diffuse large B-cell lymphomaÊs leukemic phase
Galiacho, Veronica Roldan
Gallardo, Paula Zoco
Duenas, Laura Zaldumbide
De Las Fuentes, Bernabe Davila
Garcia-Ruiz, Juan Carlos
BLOOD RESEARCH, 2023, 58 (04) : 165 - 165
[47] Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-Cell lymphomas
Kobayashi, T
Yamaguchi, M
Kim, S
Morikawa, J
Ogawa, S
Ueno, S
Suh, E
Dougherty, E
Shmulevich, I
Shiku, H
Zhang, W
CANCER RESEARCH, 2003, 63 (01) : 60 - 66
[48] Diffuse large B-cell lymphoma in the multiverse: de novo systemic diffuse large B-cell lymphoma with synchronous central nervous system involvement
Kim, D.
Taylor, K.
Bhat, A. H.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S121 - S122
[49] Outcomes of de novo CD5+diffuse large b-cell lymphoma (DLBCL) in the rituximab (R) era.
Hu, Bei
Loghavi, Sanam
Fayad, Luis
Noorani, Mansoor
Fowler, Nathan Hale
Hagemeister, Fredrick B.
Lee, Hun Ju
Nastoupil, Loretta J.
Neelapu, Sattva Swarup
Fanale, Michelle A.
Samaniego, Felipe
Turturro, Francesco
Wang, Michael
Davis, Richard Eric
Westin, Jason R.
Medeiros, L. Jeffrey
Oki, Yasuhiro
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[50] De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema
Dargent, JL
Lespagnard, L
Feoli, F
Debusscher, L
Greuse, M
Bron, D
LEUKEMIA & LYMPHOMA, 2005, 46 (05) : 775 - 780

← 1 2 3 4 5 →